Cargando…
Self-reported adverse events associated with ∆(8)-Tetrahydrocannabinol (Delta-8-THC) Use
BACKGROUND: There is an expanding unregulated market for a psychotropic compound called ∆(8)-Tetrahydrocannabinol (delta-8-THC) that is being derived from hemp, but a summary of adverse events related to delta-8-THC has not been publicly reported. METHODS: This case series assessed adverse events re...
Autores principales: | Leas, Eric C., Harati, Raquel M., Satybaldiyeva, Nora, Morales, Nicolas E., Huffaker, Shelby L., Mejorado, Tomas, Grant, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204335/ https://www.ncbi.nlm.nih.gov/pubmed/37217977 http://dx.doi.org/10.1186/s42238-023-00191-y |
Ejemplares similares
-
Brugada Electrocardiogram Pattern Induced by Recreational Delta-8-Tetrahydrocannabinol (THC): A Case Report
por: Jo, Noah Y, et al.
Publicado: (2021) -
Delta-8-THC: Delta-9-THC’s nicer younger sibling?
por: Kruger, Jessica S., et al.
Publicado: (2022) -
Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
por: Brown, Joshua D.
Publicado: (2020) -
Delta-8 Tetrahydrocannabinol Product Impurities
por: Ray, Colleen L., et al.
Publicado: (2022) -
Glucocorticoids, Stress and Delta-9 Tetrahydrocannabinol (THC) during Early Embryonic Development
por: Kuzma-Hunt, Alexander G., et al.
Publicado: (2021)